514 related articles for article (PubMed ID: 17697819)
1. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
2. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
3. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
5. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
7. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
8. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction].
Wang ZY; Liu N; Lei LC; Ren LH; Ye HM; Peng JJ
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3403-6. PubMed ID: 23327699
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
13. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
[TBL] [Abstract][Full Text] [Related]
14. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
15. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
He PC; Duan CY; Liu YH; Wei XB; Lin SG
BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
18. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
20. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction.
Celebi S; Celebi OO; Cetin S; Cetin HO; Tek M; Gokaslan S; Amasyali B; Berkalp B; Diker E; Aydogdu S
Arq Bras Cardiol; 2019 Dec; 113(6):1129-1137. PubMed ID: 31664316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
